
CAS 1422435-39-9
:Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produtos.
2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylicAcidEthylEsterHydrochloride
CAS:Fórmula:C19H22ClN5O2Pureza:98%Cor e Forma:SolidPeso molecular:387.8633Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity)
CAS:Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity)Pureza:98%Peso molecular:387.86g/molDabigatran Impurity 9 HCl
CAS:Fórmula:C19H21N5O2·HClCor e Forma:White To Off-White SolidPeso molecular:351.41 36.46Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity)
CAS:Pureza:97%Peso molecular:387.87Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran ethyl ester hydrochloride
CAS:Produto Controlado<p>Applications 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylic Acid Ethyl Ester Hydrochloride is derived from Dabigatran (D100090), which is a non-peptide, direct thrombin inhibior and anti-thrombotic.<br>References Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005)<br></p>Fórmula:C19H21N5O2·(HCl)Cor e Forma:NeatPeso molecular:351.40 + (36.46)




